Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01529-09
Full Text
Open PDFAbstract
Available in full text
Date
February 16, 2010
Authors
Publisher
American Society for Microbiology